Case of MDR-TB from Haiti Christopher Kovacs MD Infectious Disease Fellow Cleveland Clinic.

Slides:



Advertisements
Similar presentations
1 Policy Template for Communicable Diseases of Public Health Importance Spread via the Airborne and Droplet Routes Marion A. Kainer MD, MPH Tennessee Department.
Advertisements

‘Resistant infections’ Dr Julian Sutton Consultant in Infectious Diseases & Medical Microbiology.
World Health Organization TB Case Definitions
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Chapter 29 Assessment of the Respiratory System.
Clinical Case Female, 27 years of age 3 rd year Internal Medicine resident at the Mexicali General Hospital Never smoked; does not ingest alcoholic beverages.
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.
PULMONARY TUBERCULOSIS
Diagnosis and Management of TB John Yates Consultant Infectious Diseases.
TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.
Introduction to Tuberculosis
MDR and XDR TB Bruce A. Bush, M.D. Regional Tuberculosis Consultant
SURGICAL MANAGEMENT OF TUBERCULOSIS Paul Bolanowski, MD Associate Professor of Surgery Division of Cardiothoracic Surgery UMDNJ-NJ Medical School.
Tuberculosis Presented by Vivian Pham and Vivian Nguyen.
Unit 5: IPT Isoniazid TB Preventive Therapy
Management of MDR-TB patients in the hospital: LRS Institute Experience LRS Institute of TB and Respiratory Diseases Sri Aurobindo Marg, New Delhi.
Christoph Lange & Giovanni Sotgiu Principles of designing a TB and MDR-TB drug regimen.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child with a Cardiovascular Disorder.
Guidelines for chemotherapy of tuberculosis in Taiwan 馬偕紀念醫院 一般內科及感染科 主治醫師 曾祥洸
Adjuvant therapies and role of surgery in management of DR-TB 1 Dr. Ashraf Abdulhaseeb Chest Diseases Consultant Chief of DR-TB center, Abbassia Chest.
Unit 9 Diagnosis and Treatment of Paediatric TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
NYU Medical Grand Rounds Clinical Vignette Lucy Doyle MD, PGY-2 March 24, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Management of Tuberculosis (TB) and Multidrug-Resistant TB (MDR TB)
NYU Medical Grand Rounds Clinical Vignette Verity Schaye MD, PGY-2 February 3, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Microbiologists from Mexico at South Texas Hospital Lab “Microbiólogos de México en el laboratorio de South Texas Hospital”
Tuberculosis Research of INA-RESPOND on Drug-resistant
TB Control Program County of San Diego Challenges: Cross border Continuity of TB Care Response:CureTBUS/Mexico Tuberculosis Referral and Information Program.
بسم الله الرحمن الرحیم با سلام.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child With a Cardiovascular Disorder Maternity and.
Case 1: 23-year-old Male Student Clinical Director, Division of Infectious Diseases Brigham and Women’s Hospital Professor of Medicine Harvard Medical.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Management of Tuberculosis: A Surgical Perspective Alfred Lardizabal, MD Associate Professor Division of Pulmonary and Critical Care Medicine UMDNJ-NJ.
Case presentation- Tetralogy of Fallot- Ventricular Septal Defect Agatha Stanek.
Congenital Heart Lesions
International Health Policy Program -Thailand Policy decision on multi drug resistant(MDR), extreme drug resistant(XDR) tuberculosis screening: How it.
By: Michelle Russell.  To become familiar with the disease process of TB Transmission symptoms Precautions  Nursing Diagnoses  Interventions.
NYU Medical Grand Rounds Clinical Vignette Benjamin Seides, MD, MPH PGY-3 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Module 2 TB Disease Transmission & Prevention. Pulmonary Tuberculosis Extra -Pulmonary TB an infectious disease caused by a microorganism called Mycobacterium.
Post-Pneumonectomy Complications
Morgagni Hernia Brian Belyea Radiology Elective Block 8 February 27, 2004.
Clinical Case Female, 27 years of age Female, 27 years of age 3 rd year Internal Medicine resident at the Mexicali General Hospital 3 rd year Internal.
The Epidemiology of Tuberculosis Lex Gibson, Virginia TB Program.
By: Kristen Sieck and Scott Senftner 3rd Period Health Class
Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Acquired Drug Resistance  64 year old female of Hmong ethnicity with long standing, poorly controlled diabetes. No hx TB dx/tx.  11/6/08 CXR “active.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
L.A. County Public Health Partnering with the Private Community to Control TB Myrna Mesrobian, MD, MPH.
CONGENITAL HEART DISEASES
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
Treatment Regimens for Pulmonary Tuberculosis Caused by Drug- Susceptible Organisms Initial PhaseContinuation Phase RegimenDrugs Interval and Doses (Minimal.
Roundtable. Detection and treatment of TB Andrew Black.
TREATMENT OF TUBERCULOSIS: Prevention: BCG vaccination: It does not prevent infection but limits multiplication and spread of following infection so prevents.
Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis N Engl J Med 2008;359: R2 이 설 라.
Management of the Newborn When Maternal TB Suspected
Management of Tuberculosis: A Surgical Perspective
Andrew G. Cook MD, Roman Dudaryk MD, Jack Louro MD
This is an archived document.
Cardiac Manifestation of DiGeorge Syndrome
Tuberculosis.
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
بسم الله الرحمن الرحيم.
Nocardia brain abscesses
The impact of additional epicardial imaging to transesophageal echocardiography on intraoperative detection of residual lesions in congenital heart surgery 
Anti Tuberculosis Norah A A AL KHATHLAN MD 4/18/2019 Failure or MDR_TB.
One-Stage Repair of Truncus Arteriosus, CAVC, and TAPVC
Prioritizing quality improvement in pediatric cardiac surgery
Sanjiv K Gandhi, MD, Ralph D Siewers, MD, Frank A Pigula, MD 
Pulmonary Valve Repair for Patients With Acquired Pulmonary Valve Insufficiency  Sameh M. Said, MD, Richard D. Mainwaring, MD, Michael Ma, MD, Theresa.
Megan F. Hunt, BS, Xun Zhou, MD, Cecillia Lui, MD, Stephen C. Yang, MD 
Presentation transcript:

Case of MDR-TB from Haiti Christopher Kovacs MD Infectious Disease Fellow Cleveland Clinic

History of Present Illness 29 year old male from Hinche, Haiti Previous calendar year – exchange student studying agriculture Diagnosed with TOF -- referred for surgical correction at the Cleveland Clinic Preoperative assessment completed – Surgery August 2013 Haiti from May until August 2013 Returned August 2013 for surgery Fever, cough, and weight loss over the last 2 months

Previous History Past Medical History – Tetralogy of Fallot, Typhoid fever, Pleural effusion, HIV negative Past Surgical History – Thoracentesis 2009, LHC June 2013

Presentation to Cleveland Clinic Returned to US for planned surgery Preoperative testing undertaken CT chest obtained for surgical planning Sent to ED for concern of tuberculosis after interviewed, examined, and imaging reviewed

Imaging

Initial Culture Results

Drug Resistance From CDC Drug Percent ResistanceInterpretation INH100R Rifampin100R Ethambutol100R Streptomycin100R Rifabutin3.33R Ciprofloxacin0S Kanamycin0S Ethionamide66.67R Capreomycin0S PAS0S Ofloxacin0S Amikacin0S

Hospital Course Patient started on cycloserine, linezolid, amikacin, moxifloxacin, PZA and pyridoxine 9/26/2013- smear and culture negative 10/6/2013- found down with aphasia, facial droop and right sided weakness abrupt cutoff M1 segment of LMCA tPA administered; transferred to ICU PICC related paradoxical embolus

Hospital Course 12/17/13- Meeting with ID, Social work, Physical Medicine and Rehabilitation, Pediatric Cardiothoracic Surgery Re-aspiration of left pleural space negative for AFB Repeat CT scan with decreased cavity size, less infiltrate, and healed bronchopleural fistula Infection prevention plan for operative plan developed Aggressive stroke rehab

Hospital Course Successful repair of TOF – using Gore-Tex VSD patch – Right ventricular outflow tract resection – 24-mm pulmonary homograft – Suture closure of atrial septal defect All cultures remain negative to date Discharged to host family on 3/20/14

Points for Discussion Role of thoracic surgery for this patient – Considerations: – Poor blood flow to the hypoplastic left lung? – Poor drug delivery? – Sequestered area for further resistance development? – Surgical morbidity in the setting of negative cultures and resolution of the BPF? – Access to thoracic surgery resources in Haiti should intervention be required in the future? – How should this be followed going forward?

Points for Discussion Transition of care from US to Haiti – Considerations: – Patient wishes and autonomy – Resource poor vs. Resource rich environments Ensuring DOT provided; logistics of care near Hinche Duration of aminoglycoside Adjustment of regimen to consider cost/access to meds Additional susceptibilities confirmed for cycloserine, clofazimine, clarithromycin, linezolid Transition of care to GHESKO or PIH